BOOK
Alternative and Complementary Therapies for Children with Psychiatric Disorders, Part 2, An Issue of Child and Adolescent Psychiatric Clinics of North America, E-Book
(2014)
Additional Information
Book Details
Abstract
Patients in psychiatry, or their parents, experiment with alternative methods and practices. Psychiatrists, in search of scientifically-based discussion and evidence of use for daily practice, find that information in this issue of Child and Adolescent Psychiatric Clinics. Readers will find clinically focused information in the major categories of Selected Treatments, Selected Disorders, and Perspectives on Clinical Complementary and Alternative Therapies. Micronutrients for mental disorders, the role of essential fatty acids. EEG and Neurofeedback, Mind-Body Meditation and Movement Therapies, Music Therapy, are presented. Evidence for minerals, vitamins, and herbs is discussed. Guest Editors Deborah Simkin and Charles Popper, with decades of experience in working with complementary therapies, lead this issue.
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| Alternative and Complementary Therapies for Children with Psychiatric Disorders, Part 2\r | i | ||
| Copyright\r | ii | ||
| Contributors | iii | ||
| Contents | v | ||
| Child And Adolescent Psychiatric Clinics\r | vii | ||
| Preface | ix | ||
| Quantitative EEG and Neurofeedback in Children and Adolescents | 427 | ||
| Key points | 427 | ||
| Introduction | 429 | ||
| Neurofeedback basics | 430 | ||
| How Neurofeedback changes action potentials | 431 | ||
| Is all brain biofeedback alike? | 434 | ||
| Quantitative electroencephalography and its role in Neurofeedback | 434 | ||
| Validation of quantitative electroencephalography by use of neuroimaging and other techniques | 435 | ||
| Coregistration of quantitative electroencephalography with diffuse spectral imaging and other neuroimaging methods | 437 | ||
| Quantitative electroencephalography and NF for psychiatric conditions | 438 | ||
| Role of the EEG Power Spectrum, Neuromodulators, and Psychiatric Disorders | 438 | ||
| How Complex Homeostatic Systems Regulate the EEG Power Spectrum | 438 | ||
| How May This Occur in the Case of ADHD? | 439 | ||
| Psychiatry as Related to Circuitry: Moving from Categorical Disorders to Transdiagnostic Symptoms | 439 | ||
| Neurofeedback treatment in children and adolescents | 442 | ||
| Neurofeedback Treatment of Depression | 443 | ||
| Neurofeedback Treatment of Anxiety Disorders | 444 | ||
| Neurofeedback Treatment of Substance Abuse | 445 | ||
| Neurofeedback Treatment of Substance Use Disorders in the Context of Comorbid ADHD | 446 | ||
| Surface Neurofeedback Treatment of Posttraumatic Stress Disorder | 447 | ||
| Neurofeedback treatment of intrauterine brain damage, mild head injury, concussion, and TBI | 448 | ||
| Neurofeedback in Reducing Performance Anxiety | 450 | ||
| Does Neurofeedback Technique Have to be Modified for Developmental Age? | 451 | ||
| Controversies | 451 | ||
| Summary of Tables | 454 | ||
| Summary | 456 | ||
| References | 457 | ||
| Quantitative EEG Neurofeedback for the Treatment of Pediatric Attention-Deficit/Hyperactivity Disorder, Autism Spectrum Dis ... | 465 | ||
| Key points | 465 | ||
| What is neurofeedback? | 467 | ||
| Types of Neurofeedback | 468 | ||
| Controls for Neurofeedback research | 469 | ||
| Treatment outcomes in Neurofeedback research | 470 | ||
| Neurofeedback for ADHD | 470 | ||
| Neurofeedback for autism | 474 | ||
| Neurofeedback for LD | 477 | ||
| Neurofeedback for epilepsy | 479 | ||
| Safety and risks of neurofeedback | 481 | ||
| Clinical summary and clinical recommendations | 481 | ||
| References | 483 | ||
| Meditation and Mindfulness in Clinical Practice | 487 | ||
| Key points | 487 | ||
| Introduction | 489 | ||
| Meditation and Mindfulness: Evolution from Buddhist Traditions to Modern Western Techniques | 490 | ||
| Focused attention mindfulness-based interventions | 491 | ||
| Goals of Focused Attention Mindfulness-Based Intervention | 491 | ||
| Mindfulness-Based Stress-Reduction Techniques and Approaches | 491 | ||
| Mindfulness-Based Cognitive Therapy Techniques and Approaches | 492 | ||
| Dialectical Behavioral Therapy Approaches and Techniques | 492 | ||
| Acceptance and Commitment Therapy Techniques and Approaches | 492 | ||
| Mindfulness-Based Relapse Prevention Techniques and Approaches | 492 | ||
| Physiologic and Neurobiological Effects of Focused Attention Mindfulness-Based Interventions | 493 | ||
| Vipassana meditation | 493 | ||
| Mindfulness-based intervention: changing pathologic states | 494 | ||
| MRI results | 494 | ||
| Functional MRI results | 494 | ||
| Open monitoring | 495 | ||
| Goals of Open Monitoring | 495 | ||
| Open Monitoring Techniques and Approaches | 495 | ||
| Physiologic and Neurobiological Effects of Open Monitoring | 496 | ||
| Brain-wave activity | 496 | ||
| Parasympathetic activity | 496 | ||
| Automatic self-transcending or transcendental meditation | 496 | ||
| Goals of Transcendental Meditation | 497 | ||
| Transcendental Meditation Techniques and Approaches | 497 | ||
| Physiologic and Neurobiological Effects of Transcendental Meditation | 497 | ||
| Mind-body | 498 | ||
| Goals of Mind-Body Therapies | 499 | ||
| MED-RELAX Techniques and Approaches | 499 | ||
| Physiologic and Neurobiological Effects of MED-RELAX | 500 | ||
| Body-mind | 500 | ||
| Evolution from Buddhist, Chinese, and Indian/Vedic Traditions, and Modern Techniques | 500 | ||
| Goals of Body-Mind Therapies | 500 | ||
| Body-Mind Techniques and Approaches | 501 | ||
| Music Therapy and Music Medicine for Children and Adolescents | 535 | ||
| Key points | 535 | ||
| Introduction | 535 | ||
| Defining Music Therapy and Music Medicine | 535 | ||
| Mechanism of Therapeutic Action: Music and the Brain | 536 | ||
| Autism | 538 | ||
| Affective disorders | 538 | ||
| Eating disorders | 538 | ||
| Music Therapy and Mental Health Overview | 539 | ||
| Effectiveness Research | 541 | ||
| Disorders typically diagnosed in childhood | 541 | ||
| Aggressive behaviors | 542 | ||
| ADHD | 542 | ||
| General emotional and behavioral disorders | 542 | ||
| Autism | 543 | ||
| Intellectual or learning disabilities | 543 | ||
| Substance abuse | 544 | ||
| Mood/anxiety disorders | 544 | ||
| Eating disorders | 545 | ||
| Summary | 545 | ||
| References | 549 | ||
| Omega-3 Fatty Acid and Nutrient Deficits in Adverse Neurodevelopment and Childhood Behaviors | 555 | ||
| Key points | 556 | ||
| Introduction | 556 | ||
| Essential nutrients and the risk of deficiencies | 557 | ||
| The lipid substance of the brain | 557 | ||
| Excess linoleic acid and the dietary balance of omega-3 and omega-6 HUFAs | 559 | ||
| Impact of inadequate DHA intake on brain development in animals | 560 | ||
| A dietary evolution: unfortunate consequences of agricultural developments | 560 | ||
| Inadequate HUFA intake during pregnancy on human developmental outcome | 562 | ||
| Effect of HUFA supplementation in healthy children | 563 | ||
| HUFA abnormalities in ADHD | 563 | ||
| Differential Effects of EPA and DHA in the Brain | 565 | ||
| Resting-state electroencephalogram | 565 | ||
| Emotion-elicited event-related potentials | 565 | ||
| Memory-related event-related potentials in healthy fish-eating children | 566 | ||
| Individual HUFA supplementation trials in youth with ADHD or ADHD-type symptoms | 566 | ||
| Omega-3/-6 in Relation to Learning, Behavior, and Motor Skills | 566 | ||
| Randomized, double-blind, placebo-controlled clinical trials in schoolchildren | 567 | ||
| Omega-3/-6 Relation to Dyslexia | 569 | ||
| Omega-3/-6 Studies Relating to Attention and Behavior | 569 | ||
| Pharmacologic intervention and omega-3 HUFAs for ADHD | 570 | ||
| Meta-analyses and reviews of clinical efficacy of omega-3 HUFAs in ADHD | 570 | ||
| HUFAs and youth with aggressive or conduct-disordered related behaviors | 571 | ||
| HUFAs and Young Adult Prisoners | 572 | ||
| Omega-3 HUFA supplementation trials in youth and adults with depression | 573 | ||
| Dietary Intake in Youth with Depressive Symptoms | 573 | ||
| Omega-3 in Children with Depression | 573 | ||
| Omega-3 in Adults with Depression | 574 | ||
| Omega-3 and Suicide | 574 | ||
| Omega-3 HUFA and prevention of psychosis in high-risk youth | 574 | ||
| Clinical recommendations in relation to HUFAs | 575 | ||
| Cautionary findings on omega-3 supplementation | 575 | ||
| Safety and adverse effects | 577 | ||
| Summary | 578 | ||
| References | 581 | ||
| Single-Micronutrient and Broad-Spectrum Micronutrient Approaches for Treating Mood Disorders in Youth and Adults | 591 | ||
| Key points | 591 | ||
| Vitamins and minerals in health and disease | 592 | ||
| Micronutrient Functions in Biology | 592 | ||
| Micronutrient Mechanisms Leading to Disease and Dysfunction | 596 | ||
| Need for a Full and Balanced Range of Micronutrients for Optimal Functioning | 597 | ||
| Micronutrient deficiencies in the general population | 597 | ||
| Nutrient deficiencies and nutrient insufficiencies | 599 | ||
| General correlations between diet and mental health | 601 | ||
| Treatment of mood disorders with single micronutrients | 603 | ||
| Folic Acid (Vitamin B9) | 604 | ||
| Cobalamins (Vitamin B12) | 606 | ||
| Calciferols (Vitamin D) | 607 | ||
| Correlations between vitamin D levels and depression in adults | 608 | ||
| Correlations between vitamin D levels and depression in youth | 609 | ||
| Treatment of depression with vitamin D | 610 | ||
| Clinical recommendations | 610 | ||
| Pyridoxine (Vitamin B6) | 611 | ||
| Other Single Micronutrients | 613 | ||
| Chromium | 613 | ||
| Zinc | 613 | ||
| Thiamine | 617 | ||
| Selenium | 618 | ||
| Magnesium | 618 | ||
| Implications of the Single-Micronutrient Intervention Studies | 619 | ||
| Broad-spectrum micronutrient interventions | 620 | ||
| Violent and Antisocial Behavior in Youth and Adults | 621 | ||
| ADHD | 624 | ||
| Open-label trials | 624 | ||
| Controlled trials on ADHD | 626 | ||
| Mood Disorders | 629 | ||
| Open-label studies | 630 | ||
| Controlled studies of mood disorders | 632 | ||
| Clinical caveats on the micronutrient treatment of mood disorders | 633 | ||
| Summary comment on mood disorders | 635 | ||
| Micronutrients for Other Psychiatric Conditions | 636 | ||
| OCD | 636 | ||
| Autism | 636 | ||
| Substance use | 637 | ||
| Broad-Spectrum Micronutrient Interventions in Healthy Populations | 637 | ||
| Cognition in healthy adults | 637 | ||
| Cognition in healthy youth | 637 | ||
| Mood and well-being in healthy adults | 638 | ||
| Response to stress | 640 | ||
| Adverse Effects of Broad-Spectrum Micronutrient Interventions | 643 | ||
| Summary | 646 | ||
| Acknowledgments | 655 | ||
| References | 655 | ||
| Index | 673 |